Palantir outlines 2026 revenue of $8.15B-$8.158B as U.S. commercial guidance rises above $3.424B
Palantir has provided a revenue guidance for 2026 in the range of $8.15 billion to $8.158 billion, and has raised its guidance for the U.S. commercial segment to exceed $3.424 billion.
Palantir has presented a clear performance catalyst with the upward revision of its 2026 revenue and guidance for the U.S. commercial segment. The current stock price of $125.65 is positioned between the support level ($117.89) and the resistance level ($138.90), indicating approximately 10.5% upside potential to the resistance level, warranting consideration for a buy.
If the current price of $125.65 holds above the support level of $117.89, I will see an upside potential of approximately 10.5% to the resistance level of $138.90 and take profits. Conversely, if it breaks below the support level of $117.89, I will immediately cut losses.
Looking at the technical indicators at the entry point, the RSI (14) is at 41.2, indicating a somewhat weak phase just before oversold conditions, and the moving averages are in a non-aligned state. The trading volume is at 0.81 times the 20-day average, which is relatively low, and the recent 7-day volatility shows a mild downward trend of -1.2%.
Looking at the historical data for this stock, there is a pattern of positive responses around similar events, specifically on August 8, 2026 (+4.1%), August 9, 2026 (+4.1%), August 11, 2026 (+2.3%), and August 12, 2026 (+4.7%). Additionally, similar success case number 1 shares the keyword '2026 revenue guidance' and recorded a return of 38.0%. Cases number 2 (VEYE 451.7%) and number 3 (LRCX 346.8%) do not have direct similarities but serve as reference examples of top performance in the region.
At the initial entry point, based on the clear positive factors of an upward revision of the 2026 revenue and U.S. commercial segment guidance, we predicted an upside potential of approximately 10.5% supported by a price position between the support level of $117.89 and the resistance level of $138.90, along with a conservative RSI of 41.2. However, the actual result significantly exceeded the predicted return of 5.0%, recording a return of 38.0% and receiving an OVERHIT designation. In past similar cases, instances where the keyword '2026 revenue guidance' overlapped produced a pattern that resulted in a return of 38.0%, which was accurately replicated in the actual stock price response.
Through this trading, we have confirmed that the key catalyst of upward guidance revision can act as a strong upward pressure on stock prices, similar to past cases. In future trading, we will adjust our strategy to keep upward price targets more flexible, not solely constrained by short-term technical indicators' weakness (RSI 41.2, non-alignment, etc.), but rather in response to guidance upward news that stimulates core fundamentals.